Original Paper Published: 07 December 2000 The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization Kazushige Ogawa, Renata Pasqualini, Richard A Lindberg ...

CD40 ligand was originally identified on activated CD4 + T cells 5, later on stimulated mast cells and basophils 6 and most recently on activated platelets in vitro and in vivo on platelets in the ...

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 JUPITER, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that the company will ring ...

Herein, we report the synthesis of a library of 16 gold nanoparticle (AuNP) types (2, 4, 9, and 12 nm in diameter and appended with mercapto-(X-alkyl)-N,N,N-trimethylammonium bromide (MxTAB) ligands ...

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines ...

Optimization of the systems for active-targeting drug delivery is a pending task in view of more directed transport of the active components to neoplastic cells. One of the ways to improved ...